Women Undergoing Third Line Overactive Bladder Treatment Demonstrate Elevated Thermal Temporal Summation

被引:10
|
作者
Reynolds, W. Stuart [1 ]
Kowalik, Casey [1 ]
Cohn, Joshua [3 ]
Kaufman, Melissa [1 ]
Wein, Alan [4 ]
Dmochowski, Roger [1 ]
Bruehl, Stephen [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Urol Surg, A1302 Med Ctr North, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA
[3] Einstein Healthcare Network, Dept Urol, Philadelphia, PA USA
[4] Univ Penn, Dept Surg, Perelman Sch Med, Div Urol, Philadelphia, PA 19104 USA
来源
JOURNAL OF UROLOGY | 2018年 / 200卷 / 04期
基金
美国国家卫生研究院;
关键词
urinary bladder; overactive; urinary incontinence; urge; central nervous system sensitization; postsynaptic potential summation; patient reported outcome measures; CENTRAL SENSITIZATION; PAIN; SYMPTOM; VALIDATION; QUESTIONNAIRE;
D O I
10.1016/j.juro.2018.05.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We sought to determine whether women with overactive bladder who required third line therapy would demonstrate greater central sensitization, indexed by temporal summation to heat pain stimuli, than those with overactive bladder. Materials and Methods: We recruited 39 women with overactive bladder from the urology clinic who were planning to undergo interventional therapy for medication refractory overactive bladder with onabotulinumtoxinA bladder injection or sacral neuromodulation. We also recruited 55 women with overactive bladder who were newly seen at our urology clinic or who responded to advertisements for study participation. Participants underwent quantitative sensory testing using a thermal temporal summation protocol. The primary study outcome was the degree of temporal summation as reflected in the magnitude of positive slope of the line fit to the series of 10 stimuli at a 49C target temperature. We compared the degree of temporal summation between the study groups using linear regression. Results: Women in the group undergoing third line therapy showed significantly higher standardized temporal summation slopes than those in the nontreatment group (beta = 1.57, 95% CI 0.18-2.96, t = 2.25, p = 0.027). On exploratory analyses a history of incontinence surgery or hysterectomy was associated with significantly greater temporal summation. Conclusions: In this study the degree of temporal summation was elevated in women undergoing third line overactive bladder therapy compared to women with overactive bladder who were not undergoing that therapy. These findings suggest there may be pathophysiological differences, specifically in afferent nerve function and processing, in some women with overactive bladder.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [41] OVERACTIVE BLADDER IN MEN: MEDICATION ABANDONMENT AND LACK OF THIRD-LINE THERAPY
    Woff, Erika
    Cook, Thomas
    Gore, John
    Kirby, Anna
    Gill, Bradley
    JOURNAL OF UROLOGY, 2019, 201 (04): : E567 - E567
  • [42] Anticholinergics for overactive bladder: Temporal trends in prescription and treatment persistence
    Wallis, Christopher J. D.
    Lundeen, Colin
    Golda, Nicole
    Brotherhood, Hilary
    Pommerville, Peter
    Carr, Lesley
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (7-8): : 277 - 280
  • [43] Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?
    Balachandran, Aswini
    Curtiss, Natasha
    Basu, Maya
    Duckett, Jonathan
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2015, 26 (03) : 367 - 372
  • [44] Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?
    Aswini Balachandran
    Natasha Curtiss
    Maya Basu
    Jonathan Duckett
    International Urogynecology Journal, 2015, 26 : 367 - 372
  • [46] Impact of Bladder Wall Thickness on the Outcomes of Antimuscarinic Treatment in Women with Overactive Bladder
    Azab, Sherif Salah
    El Sayed, Omar
    El Kafoury, Mona
    UROLOGIA INTERNATIONALIS, 2022, 106 (03) : 291 - 297
  • [47] The effect of a counseling and training program on the treatment of women with overactive bladder
    Cayir, Gulsen
    Beji, Nezihe Kizilkaya
    PSYCHOLOGY HEALTH & MEDICINE, 2022, 27 (08) : 1726 - 1738
  • [48] COMPLIANCE AND TREATMENT PERSISTENCE OF DARIFENACIN FOR WOMEN WITH OVERACTIVE BLADDER SYMPTOMS
    Grigoriadis, T.
    Athanasiou, S.
    Sotiropoulou, M.
    Antsaklis, A.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S182 - S182
  • [50] Overactive bladder in menopausal women - estimate treatment of antimuscarinic drugs
    Pertyhskil, Tomasz
    Willamowskal, Agnieszka
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2007, 6 (03): : 145 - 149